Figure 1From: Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial Autologous E. coli autovaccine in house dust mite asthma. Figure 1 illustrates the study design of the trialBack to article page